Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Twist Bioscience Corporation (TWST) Misses Q3 EPS by 7c
August 6, 2021 7:38 AM EDTTwist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.82), $0.07 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $35 million versus the consensus estimate of $32.27 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2021 revenue of $129-132 million, versus the... More
